Working towards eradication of CV risk

10' education - Dec. 15, 2021 - Prof. Erik Stroes, MD, PhD - Amsterdam, The Netherlands

Achieving LDL-c target, measurements of risk factors, and a need for tailored therapy choices are three important factors to reduce (residual) CV risk. Prof. Stroes briefly discusses these three topics.

Video navigation menu

Achieving target LDL-c 0:08
The risk factor Lp(a) 2:30
Six pillars of (residual) CV risk 3:49

Faculty

Prof. Erik Stroes, MD, PhD is professor of Vascular Medicine at Amsterdam University Medical Centers in Amsterdam, The Netherlands.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.